Oruka Therapeutics (ORKA) Misses Q1 EPS by 40c
Tweet
Share
E-mailGet Alerts ORKA Hot Sheet
Join SI Premium – FREE
Oruka Therapeutics (NASDAQ: ORKA) reported Q1 EPS of ($0.40).
For earnings history and earnings-related data on Oruka Therapeutics (ORKA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
- Zoom (ZM) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
- Texas Community Bancshares (TCBS) Declares $0.06 Quarterly Dividend; 1.4% Yield
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
